WP
BPMC
Woodline Partners’s Blueprint Medicines BPMC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.2M | Sell |
531,880
-8,858
| -2% | -$1.14M | 0.36% | 55 |
|
|
2025
Q1 | $47.9M | Buy |
540,738
+546
| +0.1% | +$48.3K | 0.31% | 92 |
|
|
2024
Q4 | $47.1M | Buy |
540,192
+86,614
| +19% | +$7.55M | 0.32% | 84 |
|
|
2024
Q3 | $42M | Sell |
453,578
-426,569
| -48% | -$39.5M | 0.35% | 87 |
|
|
2024
Q2 | $94.9M | Buy |
880,147
+52,974
| +6% | +$5.71M | 0.91% | 17 |
|
|
2024
Q1 | $78.5M | Buy |
827,173
+12,700
| +2% | +$1.2M | 0.72% | 23 |
|
|
2023
Q4 | $75.1M | Buy |
814,473
+212,446
| +35% | +$19.6M | 0.82% | 25 |
|
|
2023
Q3 | $30.2M | Buy |
602,027
+310,665
| +107% | +$15.6M | 0.35% | 71 |
|
|
2023
Q2 | $18.4M | Buy |
291,362
+185,985
| +176% | +$11.8M | 0.22% | 142 |
|
|
2023
Q1 | $4.74M | Sell |
105,377
-135,317
| -56% | -$6.09M | 0.06% | 300 |
|
|
2022
Q4 | $10.5M | Buy |
240,694
+147,307
| +158% | +$6.45M | 0.14% | 198 |
|
|
2022
Q3 | $6.15M | Sell |
93,387
-22,700
| -20% | -$1.5M | 0.09% | 260 |
|
|
2022
Q2 | $5.86M | Buy |
116,087
+91,214
| +367% | +$4.61M | 0.09% | 238 |
|
|
2022
Q1 | $1.59M | Sell |
24,873
-37,182
| -60% | -$2.38M | 0.03% | 410 |
|
|
2021
Q4 | $6.65M | Sell |
62,055
-109,980
| -64% | -$11.8M | 0.1% | 248 |
|
|
2021
Q3 | $17.7M | Buy |
172,035
+114,979
| +202% | +$11.8M | 0.29% | 97 |
|
|
2021
Q2 | $5.02M | Sell |
57,056
-31,850
| -36% | -$2.8M | 0.09% | 216 |
|
|
2021
Q1 | $8.64M | Buy |
+88,906
| New | +$8.64M | 0.19% | 138 |
|